Amylx Pharmaceuticals Inc vs Hut 8 Corp — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Hut 8 Corp trades at $96.33 (market cap $10.94B). The key difference: Hut 8 Corp is far larger — about 4.1× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Hut 8 Corp nearer its low. Which is the better fit depends on your goals.
| AMLX | HUT | |
|---|---|---|
Market Cap | $2.64B | $10.94B |
Sector | Health | Technology |
52-Week High | $24.19 | $133.02 |
52-Week Low | $7.82 | $21.37 |
Enterprise Value | $2.39B | $18.38B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →